✦ LIBER ✦
5031 Overall response rate (ORR) and clinical benefit (CB) as clinical indicators for the efficacy of sequential Aromatase Inhibitors (AIs) in 3rd line hormonal treatment (HT) for advanced breast cancer (ABC): pooled analysis of phase II studies
✍ Scribed by V. Vaccaro; E. Bria; F. Cuppone; M. Milella; C. Nisticò; I. Sperduti; D. Giannarelli; F. Cognetti; P. Carlini
- Book ID
- 119600681
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 47 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.